New hope for boys with DMD: first human trial of potential Muscle-Saving drug begins

NCT ID NCT06053814

Summary

This is the first study in humans of a new drug called NS-050/NCNP-03 for boys with Duchenne muscular dystrophy (DMD). The main goals are to check if the weekly injections are safe and to see how the drug moves through the body. Researchers will also measure if the treatment helps produce more of a crucial muscle protein called dystrophin in boys with a specific genetic change.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DUCHENNE MUSCULAR DYSTROPHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Alberta Children's Hospital

    NOT_YET_RECRUITING

    Calgary, Alberta, Canada

    Contact Email: •••••@•••••

  • Ankara Bilkent City Hospital

    NOT_YET_RECRUITING

    Ankara, Turkey (Türkiye)

  • Ann & Robert H. Lurie Children's Hospital of Chicago

    RECRUITING

    Chicago, Illinois, 60611, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • British Columbia Children's Hospital

    NOT_YET_RECRUITING

    Vancouver, British Columbia, Canada

    Contact Email: •••••@•••••

  • Children's Hospital Colorado

    RECRUITING

    Aurora, Colorado, 80011, United States

    Contact Email: •••••@•••••

  • Children's Hospital Los Angeles

    NOT_YET_RECRUITING

    Los Angeles, California, 90027, United States

    Contact Email: •••••@•••••

  • Children's Hospital of Philadelphia

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hyogo Medical University Hospital

    RECRUITING

    Nishinomiya, Hyōgo, 663-8501, Japan

  • Istanbul University

    NOT_YET_RECRUITING

    Istanbul, Turkey (Türkiye)

  • London Health Sciences Centre

    RECRUITING

    London, Ontario, Canada

    Contact Email: •••••@•••••

  • NHO Osaka Toneyama Medical Center

    RECRUITING

    Toyonaka, Osaka, 560-8552, Japan

    Contact Email: •••••@•••••

  • National Center of Neurology and Psychiatry

    RECRUITING

    Kodaira, Tokyo, 187-8551, Japan

  • National Hospital Organization Nagara Medical Center

    RECRUITING

    Nagara, Gifu, 502-8558, Japan

    Contact Email: •••••@•••••

    Contact Email: •••••@•••••

  • Pusan National University Yangsan Hospital

    RECRUITING

    Yangsan, Gyeongsangnam-do, South Korea

    Contact Email: •••••@•••••

  • Seoul National University Hospital

    NOT_YET_RECRUITING

    Seoul, South Korea

    Contact Email: •••••@•••••

  • University of Kansas Medical Center

    RECRUITING

    Kansas City, Kansas, 66103, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Pittsburgh Medical Center

    RECRUITING

    Pittsburgh, Pennsylvania, 15213, United States

    Contact Email: •••••@•••••

  • Yeditepe University Kosuyolu Hospital

    NOT_YET_RECRUITING

    Istanbul, Turkey (Türkiye)

Conditions

Explore the condition pages connected to this study.